How much cost for hiv test. Cost of Rapid HIV Testing at 45 U.S. Hospitals
How much does an HIV test cost? What are the costs of rapid HIV testing at hospitals in the U.S.? Find out the details.
The Cost of Rapid HIV Testing at U.S. Hospitals
HIV testing is a crucial step in the prevention and management of the HIV/AIDS epidemic. Knowing one’s HIV status is the first step towards seeking appropriate medical care and preventing the further spread of the virus. The cost of HIV testing, particularly rapid testing, has been a concern for many individuals and healthcare providers. To shed light on this issue, a recent study published in the Journal of the American Medical Association (JAMA) examined the costs of rapid HIV testing at 45 hospitals across the United States.
Methodology of the Study
The researchers conducted a retrospective analysis of data from 45 U.S. hospitals that offered rapid HIV testing between 2009 and 2010. They collected information on the direct costs associated with the rapid HIV testing, including the costs of supplies, labor, and any required confirmatory testing. The study aimed to provide a comprehensive understanding of the financial implications of implementing rapid HIV testing in the hospital setting.
Findings of the Study
The study found that the overall median cost of a single rapid HIV test was $28.55, with a range of $13.86 to $70.38 across the 45 hospitals. The direct costs of the test kits themselves accounted for the largest portion of the total cost, at a median of $16.78 per test. Labor costs, which included the time spent by healthcare providers to perform the test and provide counseling, had a median of $8.32 per test.
Interestingly, the study also found that the costs of rapid HIV testing varied significantly across different hospital settings. Factors such as the volume of tests performed, the type of rapid test used, and the specific protocols followed by the hospitals all contributed to the observed cost variations.
Implications of the Findings
The findings of this study have important implications for the provision of HIV testing services in the United States. The relatively high cost of rapid HIV testing, particularly in comparison to other diagnostic tests, can be a barrier to widespread implementation and uptake of this critical service.
However, the study also highlights the potential for cost optimization through factors such as increased testing volume, use of more cost-effective rapid test kits, and streamlined testing protocols. By addressing these cost drivers, healthcare providers and policymakers can work to make rapid HIV testing more accessible and affordable for individuals who need it.
Factors Affecting the Cost of Rapid HIV Testing
What are the key factors that influence the cost of rapid HIV testing at U.S. hospitals? Some of the main factors include:
- Test Kit Costs: The cost of the rapid HIV test kits themselves, which can vary depending on the manufacturer and the specific test being used.
- Labor Costs: The time and effort required by healthcare providers to perform the test, provide counseling, and document the results.
- Confirmatory Testing: The need for additional, more complex testing to confirm a positive rapid test result.
- Testing Volume: Hospitals that perform a higher volume of rapid HIV tests may be able to benefit from economies of scale and lower per-test costs.
- Hospital Protocols: The specific procedures and policies in place at each hospital for conducting rapid HIV testing.
Addressing the Cost Barriers to Rapid HIV Testing
To overcome the cost barriers and make rapid HIV testing more accessible, healthcare providers and policymakers can consider the following strategies:
- Negotiating Lower Test Kit Prices: Leveraging the purchasing power of healthcare systems to negotiate discounted rates for rapid HIV test kits from manufacturers.
- Streamlining Testing Protocols: Implementing efficient, standardized procedures for conducting rapid HIV tests and providing counseling to minimize labor costs.
- Increasing Testing Volume: Promoting widespread adoption of rapid HIV testing to drive down per-test costs through economies of scale.
- Exploring Alternative Funding Sources: Seeking out grant funding, public health initiatives, or insurance reimbursement to offset the costs of rapid HIV testing programs.
- Educating Patients on the Importance of Testing: Raising awareness and addressing any stigma or misconceptions that may deter individuals from seeking HIV testing services.
Conclusion
The cost of rapid HIV testing at U.S. hospitals is an important consideration in the broader effort to expand access to this critical preventive service. While the findings of this study highlight the financial challenges, they also point to opportunities for cost optimization and innovative solutions to make rapid HIV testing more affordable and accessible for all individuals who need it.
Where To Get Tested For HIV / AIDS?
In This Section
What is HIV & AIDS?
What are the symptoms of HIV & AIDS?
Should I get tested for HIV?
How do I get treated for HIV?
How do I prevent HIV?
Living with HIV
What is PrEP?
What is PEP?
Getting tested is the only way to find out if you have HIV.
HIV tests are recommended for all adults. HIV tests are quick, painless, and sometimes free.
How do I know if I have HIV?
The only way to know for sure if you have HIV is to get tested. You can’t tell if you have HIV just by the way you feel, because most people who get HIV don’t have any symptoms for years.
Testing is a good idea if you’ve had unprotected sex or if your partner tests positive for HIV. You should also get tested if you’ve shared needles with anybody (for shooting drugs, piercings, or tattoos). If you’re pregnant, get tested for HIV at your first prenatal visit.
Luckily, HIV testing is pretty easy and painless. The best part about getting tested for HIV? Once you get it over with, it can really put your mind at ease. And if you DO have HIV, it’s best to find out right away so you can take medicines to help you stay healthy and lower your chances of spreading HIV to others.
How do HIV tests work?
When you get HIV, your immune system makes antibodies that try to fight off the infection.
The most common type of HIV test looks for these antibodies in your blood or cells from your cheek.
It usually takes about 3 months for your body to make enough antibodies to show up on an HIV test, but it could be even longer. This time after you first get infected but won’t test positive for HIV is called the “window period.” If you get tested during this time, you can get a negative result even if you do actually have HIV. You also have the biggest chance of giving HIV to other people during the window period.
What kind of HIV tests are there?
Rapid HIV tests give you results in about 20 minutes. Other tests take longer because they need to be sent out to a lab. HIV tests are usually painless — you just gently rub the inside of your cheek with a soft swab. Sometimes you’ll give a blood sample for testing.
You can test yourself for HIV using an at-home HIV testing kit. With the OraQuick In-Home HIV Test, you swab your gums and test the sample yourself. You get results in 20 minutes.
With the Home Access HIV-1 Test, you prick your finger to get a small amount of blood. You mail your blood sample to a lab, and get your results in about a week. At-home tests are totally anonymous — you’re the only person who will know the results. And both types of tests help connect you with counselors who can give you support and advice about treatment if you test positive.
If a rapid HIV test at a clinic or a home test shows that you have HIV, get a follow-up test to make sure the results are correct.
Where can I go for HIV testing?
You can get tested for HIV and other STDs at your doctor’s office, a community health clinic, the health department, or your nearest Planned Parenthood health center. You might want to get your HIV test at a place that also has HIV counseling (like Planned Parenthood).
You can either get an “anonymous” or “confidential” HIV test, depending on the laws in the state that you live in. “Confidential” testing means your name is on the test, and the results go in your medical records.
Your doctors and insurance company may also see the results. If you test positive, your results are sent to your local health department so they know the rates of HIV in your area. But your results are protected by privacy laws, so nobody else can see them without your permission.
“Anonymous” testing means your name isn’t on the test. You’ll get an ID number that you’ll use to find out your results. Your results won’t go in your medical records, and they won’t be sent to your insurance company or the health department — you’re the only one who will know them.
STD testing, including HIV testing, isn’t usually automatically part of your regular checkup or gynecologist exam — you have to ask for it directly. Be honest with your nurse or doctor so they can help you figure out what tests are best for you. Don’t be embarrassed: your doctor is there to help, not to judge. (And if your doctor does judge you for asking for an HIV test, maybe it’s time to find a new one.)
The idea of getting tested may seem scary, but try not to freak out.
STD testing is part of being responsible and taking care of your health. HIV tests are quick and usually painless. And if you do have HIV, it’s better to know as soon as possible so you can start treatment.
More questions from patients:
Where can I get free HIV testing?
Lots of places! Your local health department may offer free testing, or if you’re a student, your college or university health center may have free HIV testing. Low and no-cost tests are often available from Planned Parenthood health centers and many doctor’s offices, hospitals, and health clinics. Some organizations even set up mobile testing trailers in different cities around the US.
One benefit to visiting a doctor or nurse, like the staff at your nearest Planned Parenthood health center, is being able to talk with someone face-to-face and ask questions about your results.
Keep your eyes open for free testing in your area, do some searching online, or call your nearest Planned Parenthood health center to find out where you can get free HIV testing.
How accurate are HIV tests?
HIV tests are very accurate. When you get HIV, your immune system makes antibodies that try to fight off the infection. It usually takes about 3 months for your body to make enough antibodies to show up on an HIV test. So the first 3 months after infection is called the “window period.” If you get tested during this time, you can get a negative result even if you do actually have HIV.
So depending on when you were tested for HIV, you may need another test to be sure that you weren’t in the window period. You also have the biggest chance of giving HIV to other people during the window period.
Rapid HIV tests (where you get the results in about 20 minutes), and at home HIV tests aren’t quite as accurate as other tests at a clinic that get processed in a lab. So if you get a positive rapid or at-home test, follow up with another test at a health center. You can get an HIV test at your local Planned Parenthood health center.
Was this page helpful?
Yes
No
Help us improve – how could this information be more helpful?
How did this information help you?
Please answer below.
Are you human? (Sorry, we have to ask!)
Please don’t check this box if you are a human.
You’re the best! Thanks for your feedback.
Thanks for your feedback.
HIV Testing Cost without Insurance | Quest
If you need more than just HIV-1 DNA, Qualitative, PCR lab test – add more tests one by one.
Please select an item from the autocomplete list
Max stores per result:
Any12345678910111213141516171819Verbose:
See search details
(0.
0 seconds, 5 steps, 5 combinations
)
Laboratory tests search details
HIV-1 DNA, Qualitative, PCR (test)
(remove)
Stores: HealthLabs, Jason Health, LabsMD, Private MD, Walk-In Lab
Quest test: 8401
(Quest)
Components: HIV 1 DNA, Qual, PCR
HIV Testing Cost without Insurance
minimal is in Jason Health (HIV-1 DNA, Qualitative, PCR) with price $138.00.
HIV Testing Cost without Insurance
max is in Private MD (Child Caregiver Infectious Disease Profile) with price $524.99.
This laboratory test is available in 5 online lab test stores.
$138.00
Order
Jason Health
HIV-1 DNA, Qualitative, PCR
Covered tests:
HIV-1 DNA, Qualitative, PCR
(Quest)
Covered components:
HIV 1 DNA, Qual, PCR
Blacklisted States: NY, NJ, RI
$120.
00Jason Health
Requisition Charge (per order charge)
$18.00
$138.00
Order from Jason Health
- HIV-1 DNA, Qualitative, PCR $120.00
Go to
Checkout
and complete the checkout process there.
Your total price should be
$138.00($120.00 panels price + $18.00 requisition charge)
$198.00
Walk-In Lab
HIV-1 DNA Blood Test, Qualitative, PCR
Covered tests:
HIV-1 DNA, Qualitative, PCR
(Quest)
Covered components:
HIV 1 DNA, Qual, PCR
Blacklisted States: NY, NJ, RI
$198.00
$198.00
Order from Walk-In Lab
Step 1: Add to cart – for each panel below click “Buy Online” button. This will open in a new
tab.
Click “Add to Cart” button there, and then close the tab.- Click Buy Online
then “Add to Cart” button in the new tab. Close the tab. (HIV-1 DNA Blood Test, Qualitative, PCR $198.00)
Step 2: Checkout – go to
Checkout
and complete the checkout process there. Your total price should be
$198.00- Click Buy Online
$375.00
HealthLabs
Early Detection Comprehensive Panel
Covered tests:
HIV-1 DNA, Qualitative, PCR
(Quest)
,Extra tests (click to add to search):
Neisseria gonorrhoeae RNA, TMA, Urogenital
(Quest)
,Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital
(Quest)
,SureSwab®, Trichomonas vaginalis RNA, Qualitative, TMA
(Quest)
,Hepatitis A IgM Antibody
(Quest)
,RPR (Monitor) with Reflex to Titer
(Quest)
,Hepatitis B Surface Antigen, Quantitative, Monitoring (Not for Diagnosis)
(Quest)
Covered components:
HIV 1 DNA, Qual, PCR
Extra components (click to add to search):
Neisseria gonorrhoeae RNA, TMA, Urogenital,
Chlamydia trachomatis RNA, TMA, Urogenital,
Sureswab(R) Trichomonas vaginalis RNA, Ql, TMA,
Hepatitis A IgM,
RPR (Monitor) w/Refl Titer,
Hepatitis B Surface AG,Qn Monitor (Not for Diag)
Blacklisted States: MD, NJ, NY, RI
$375.
00$375.00
Order from HealthLabs
Step 1: Add to cart – for each panel below click “Buy Online” button. This will open in a new
tab.
Click “Add to Cart” button there, and then close the tab.- Click Buy Online
then “Add to Cart” button in the new tab. Close the tab. (Early Detection Comprehensive Panel $375.00)
Step 2: Checkout – go to
Checkout
and complete the checkout process there. Your total price should be
$375.00- Click Buy Online
$499.99
LabsMD
Child Caregiver Infectious Disease Profile
Covered tests:
HIV-1 DNA, Qualitative, PCR
(Quest)
,Extra tests (click to add to search):
Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital
(Quest)
,RPR (Diagnosis) with Reflex to Titer and Confirmatory Testing
(Quest)
,Hepatitis B Core Antibody (IgM)
(Quest)
,Hepatitis B Surface Antibody, Qualitative
(Quest)
,Hepatitis A IgM Antibody
(Quest)
,Herpes Simplex Virus 1 and 2 (IgG), Type-Specific Antibodies
(Quest)
,Hepatitis C Antibody with Reflex to HCV, RNA, Quantitative, Real-Time PCR
(Quest)
Covered components:
HIV 1 DNA, Qual, PCR
Extra components (click to add to search):
Chlamydia trachomatis RNA, TMA, Urogenital,
Neisseria gonorrhoeae RNA, TMA, Urogenital,
RPR (DX) w/Refl Titer and Confirmatory Testing,
Hepatitis B Core Antibody (IgM),
Hepatitis B Surface Antibody Ql,
Hepatitis A IgM,
HSV 1 IgG, Type Specific Ab,
HSV 2 IgG, Type Specific Ab,
Hepatitis C Antibody,
Blacklisted States: NY, NJ, MA, MD, RI
$499.
99$499.99
Order from LabsMD
Step 1: Add to cart – for each panel below click “Add to Cart” button and then close the new
tab.- Click Add to Cart
then close the new tab (Child Caregiver Infectious Disease Profile $499.99)
Step 2: Checkout – go to
Checkout
and complete the checkout process there. Your total price should be
$499.99- Click Add to Cart
$524.99
Private MD
Child Caregiver Infectious Disease Profile
Covered tests:
HIV-1 DNA, Qualitative, PCR
(Quest)
,Extra tests (click to add to search):
Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital
(Quest)
,RPR (Diagnosis) with Reflex to Titer and Confirmatory Testing
(Quest)
,Hepatitis B Core Antibody (IgM)
(Quest)
,Hepatitis B Surface Antibody, Qualitative
(Quest)
,Hepatitis A IgM Antibody
(Quest)
,Herpes Simplex Virus 1 and 2 (IgG), Type-Specific Antibodies
(Quest)
,Hepatitis C Antibody with Reflex to HCV, RNA, Quantitative, Real-Time PCR
(Quest)
Covered components:
HIV 1 DNA, Qual, PCR
Extra components (click to add to search):
Chlamydia trachomatis RNA, TMA, Urogenital,
Neisseria gonorrhoeae RNA, TMA, Urogenital,
RPR (DX) w/Refl Titer and Confirmatory Testing,
Hepatitis B Core Antibody (IgM),
Hepatitis B Surface Antibody Ql,
Hepatitis A IgM,
HSV 1 IgG, Type Specific Ab,
HSV 2 IgG, Type Specific Ab,
Hepatitis C Antibody,
$524.
99$524.99
Order from Private MD
Step 1: Add to cart – for each panel below click “Buy Online” button. This will open in a new
tab.
Click “Add to Cart” button there, and then close the tab.- Click Buy Online
then “Add to Cart” button in the new tab. Close the tab. (Child Caregiver Infectious Disease Profile $524.99)
Step 2: Checkout – go to
Checkout
and complete the checkout process there. Your total price should be
$524.99- Click Buy Online
00
Close the tab. (HIV-1 DNA Blood Test, Qualitative, PCR $198.00)
00
99
99Lab Tests Catalog
- >
STD Testing - >
HIV-1 DNA, Qualitative, PCR
HIV-1 DNA, Qualitative, PCR Lab Test Short Info
HIV-1 DNA, Qualitative, PCR Lab Test procedure CPT Code: 87535
Screening for the next conditions: HIV Infection and AIDS, Sexually Transmitted Diseases, Travelers’ Diseases
Understanding of Lab Tests Results
Please visit the page about HIV antibody test on the
site associated with The American Association for Clinical Chemistry (AACC) for better understanding of tests.
There you will find the most detailed and full information regarding lab tests. In “common questions” tab you will find answers on the most common questions.
In addition, you can use a special form to ask the question. It is useful, if there is no answer on your question on the web site. A laboratory scientist will answer your question. It is a part of voluntary service provided by the American Society for Clinical Laboratory Science.
Related Lab Tests to HIV-1 DNA, Qualitative, PCR Test :
Take an HIV test, the price of an AIDS test in Moscow in Invitro
I confirm
More
- INVITRO
- Diagnosis…
- Viral infections
- Immunodeficiency virus…
- Antibodies to HIV 1 and 2 and…
org/ListItem”> Analyzes- Survey program for office workers
- Household staff screening
- Cardiovascular risk assessment
- Antiphospholipid syndrome (APS) diagnosis
- COVID-19
- Liver function assessment
- Kidney and genitourinary assessment 900 06
- Diagnosis of the condition of the gastrointestinal tract
- Diagnosis of connective tissue diseases
- Diagnosis of diabetes mellitus
- Diagnosis of anemia
- Oncology
- Diagnosis and control of osteoporosis therapy
- Blood biochemistry
- Diagnosis of the state of the thyroid gland
- Hospital profiles
- Healthy, healthy country
- Gynecology, re products
- Healthy baby: for children from 0 to 14 years old
- Infections sexually transmitted diseases (STIs)
- Weight problems
- VIP examinations
- Respiratory diseases
- Allergies
- Determination of micronutrient reserves in the body
- Beauty
- Vitamins
- Diets
- Laboratory tests before dieting
- Sports profiles
- Hormonal tests for men
- De pressure
- Laboratory tests for obtaining medical certificates
- Biochemical studies
- Glucose and metabolites of carbohydrate metabolism
- Proteins and amino acids
- Bile pigments and acids
- Lipids
- Enzymes
- Markers of kidney function
- Inorganic substances/electrolytes:
- Vitamins
- Proteins involved in iron metabolism 900 06
- Cardiospecific proteins
- Markers of inflammation
- Markers of bone tissue metabolism and osteoporosis
- Determination of drugs and psychoactive substances
- Biogenic amines
- Specific proteins
- Hormonal studies
- Laboratory assessment of the pituitary-adrenal system
- Laboratory assessment of the somatotropic function of the pituitary gland
- Laboratory assessment of thyroid function
- Assessment of the function of the parathyroid glands 90 006
- Pituitary gonadotropins and prolactin
- Estrogens and progestins
- Androgenic functions
- Nonsteroidal sex gland regulatory factors
- Pregnancy monitoring, biochemical markers of fetal status
- Laboratory assessment of pancreatic endocrine function and diagnosis of diabetes
- Biogenic amines
- Laboratory assessment of the renin-angiotensin-aldosterone system
- Factors involved in the regulation of appetite and fat th exchange
- Laboratory assessment of the state of the endocrine functions of the gastrointestinal tract
- Laboratory assessment of hormonal regulation of erythropoiesis
- Laboratory evaluation of pineal gland function
- Healthy lifestyle tests
- Hematological tests
- Clinical blood test
- Immunohematological tests
- Coagulological tests (coagulus gram)
- Immunological studies
- Comprehensive immunological studies
- Lymphocytes, subpopulations
- Phagocytosis assessment
- Immunoglobulins
- Complement components
- Regulators and mediators of immunity
- Interferon status, assessment of sensitivity to immunotherapeutic drugs:
- Allergological studies
- IgE – allergen-specific (allergotests), mixtures, panels, total IgE .
- IgG, allergen-specific
- ImmunoCAP technology
- AlcorBio technology
- ALEX technology
- IgE – allergen-specific (allergotests), mixtures, panels, total IgE .
- Autoimmune disease markers
- Systemic diseases of the connective tissue
- Rheumatoid arthritis, joint damage
- Antiphospholipid syndrome
- Vasculitis and kidney damage
- Autoimmune lesions of the gastrointestinal tract. Celiac disease
- Autoimmune liver diseases
- Neurological autoimmune diseases
- Autoimmune endocrinopathies
- Autoimmune skin diseases
- Lung and heart diseases
- Immu present thrombocytopenia
- Tumor markers
- COVID-19
- Trace elements
- Aluminum
- Barium
- Beryllium
- Boron
- Vanadium
- Bismuth
- Tungsten
- Gallium
- Germanium
- Iron
- Gold
- Iodine
- Cadmium
- Potassium
- Calcium
- Cobalt
- Silicon
- Lanthanum
- Lithium
- Magnesium
- Manganese
- Copper
- Molybdenum
- Arsenic
- Sodium
- Nickel
- Tin
- Platinum
- Mercury
- Rubidium
- Lead
- Selenium
- Silver
- Strontium
- Antimony
- Thallium
- Phosphorus 9000 6
- Chromium
- Zinc
- Zirconium
- Examination of the structure of the kidney stone
- Urinalysis
- Clinical analysis of urine
- Urinalysis
- Fecal examination
- Fecal examination
- Fecal chemistry
- Semen examination
- Light optical examination of spermatozoa
- Electron microscopic examination of semen
- Antisperm antibodies
- Diagnosis of infectious diseases
- Viral infections
- Bacterial infections
- Fungal infections
- Parasitic infections
- Streptococcal infections
- Cytological studies
- Histological studies
- Oncogenetic studies
- Cytogenetic studies research
- Non-invasive prenatal tests
- Genetic predispositions
- Lifestyle and genetic factors
- Reproductive health
- Immunogenetics
- Rh factor
- Blood coagulation system
- Diseases of the heart and blood vessels
- Diseases of the gastrointestinal tract
- Diseases of the central nervous system
- Oncological diseases
- Metabolic disorders
- Description of the results of genetic research by a geneticist
- Pharmacogenetics
- Xenobiotic detoxification system and carcinogens
- Fetal sex determination
- Fetal Rh factor
- Hereditary diseases
- Hereditary metabolic diseases
- Hereditary metabolic diseases
- Additional studies (after screening and consultation with a specialist)
- Determination of biological relationship: paternity and motherhood
- 90 019 Determination of biological relationship in the family: paternity and motherhood
- Biochemical studies
- Water and soil quality survey
- Water quality survey
- Soil quality testing
- Diagnosis of liver pathology without biopsy: FibroMax, FibroTest, SteatoScreen
- Calculated tests performed based on SteatoScreen results without blood sampling
- Di sbiotic conditions of the intestines and urogenital tract
- General assessment of the natural microflora of the body
- Study of microbiocenosis of the urogenital tract
- Femoflor: profiles of studies of dysbiotic conditions of the urogenital tract in women
- Specific assessment of the natural microflora of the body
- Test results form in English
- Blood
- Urine 900 06
- Cal
- Spermogram
- Gastropanel
- Endoscopy
- Functional diagnostics
- ultrasound
- Examinations we do not do
- New tests
- Obtaining results
- Additional research orders
- Medical consultant service
- Professional position
- Venous blood for analysis
- Tumor markers. View of a practical oncologist. Laboratory justifications.
- Testosterone: diagnostic threshold, method-dependent reference values
- Laboratory assessment of lipid parameters in INVITRO
- Lipid profile: fasting or not fasting
View of a practical oncologist. Laboratory justifications.The cost of analyzes is indicated without taking biomaterial
Description
Method of determination
Chemiluminescent immunoassay, a combined test aimed at the simultaneous detection of antibodies to HIV 1, 2 and p24 antigen.
Test material
Blood serum
Home visit available
Attention! In case of positive and doubtful reactions, the term for issuing the result can be extended up to 10 working days.
Synonyms: Blood test for HIV1 and 2 antibodies and HIV1 and 2 antigen; HIV-1 p24; HIV-1 antigen, p24 antigen; HIV 1 and 2 antibodies and p24/25 antigen, 4th generation HIV test systems; Simultaneous qualitative determination of HIV p24 antigen and antibodies to HIV antigens types 1 and 2.
Anti-HIV, HIV antibodies, human immunodeficiency virus antibodies; HIV-1 p24, HIV-1 Ag, p24-antigen; HIV-1 and HIV-2 Antibody and Antigen Evaluation; HIV Screening Tests; AIDS Test; AIDS Screen; HIV Serology.
Brief description of the test for Antibodies to HIV 1 and 2 and Antigen of HIV 1 and 2
Antibodies to HIV may appear from the second week after infection. Their content increases within 2-4 weeks and persists for many years. In 90-95% of those infected, they appear in the first three months after infection, in 5-9% – in the period from three to six months, in 0.5-1% – at a later date. After HIV infection, even before the appearance of antibodies (seroconversion), HIV antigens can be detected in serum or plasma samples. Structural nuclear protein HIV p24, which appears in the blood two weeks after infection, disappears only after two months. The test system of the 4th generation, with which this test is performed, allows, in addition to detecting antibodies to HIV 1 and 2, to detect the HIV p24 antigen.
Thus, the study can be informative even before seroconversion. This approach in the laboratory diagnosis of HIV allows for the earliest detection of infection. The special characteristics of the Invitro test used in the laboratory to detect HIV infection include the high specificity of the study: > 99.5%; 100% sensitivity of the assay to antibodies characteristic of the period of seroconversion, and the sensitivity of the test to the p24 antigen is about 18 pg/ml.
Most people with HIV antibodies may not show clinical signs of the disease (AIDS) for two to ten years or more. The procedure for conducting a laboratory examination for the presence of HIV antigens and antibodies to HIV is strictly regulated by orders of the Ministry of Health of the Russian Federation and includes the stage of a screening (screening) study by enzyme immunoassay (ELISA) methods approved for use, and the stage of a verification (confirming) study by the immunoblot method in the laboratory of the city center AIDS.
It should be noted that even the best diagnostic ELISA systems do not have 100% specificity, that is, there is some possibility of obtaining non-specific, false positive results associated with the characteristics of the patient’s blood serum. Therefore, a positive screening ELISA result may not be confirmed in a confirmatory test, after which the patient will be given a negative result. If indeterminate results are obtained in a confirmatory study, testing is repeated over time. It is recommended to re-examine after 2-3 weeks.
Laboratory diagnosis of HIV infection in children born to HIV-infected mothers has its own characteristics. In their blood up to 18 months from the moment of birth, maternal antibodies to HIV (IgG class) can circulate. The absence of antibodies to HIV in newborns does not mean that the virus has not crossed the placental barrier. Children of HIV-infected mothers are subject to laboratory diagnostic examination within 36 months after birth.
What is the purpose of testing for HIV 1 and 2 antibodies and HIV 1 and 2 antigen
The test is used to detect HIV, including at the preclinical stage of the disease.
The combined determination of specific antibodies to HIV types 1 and 2 and the HIV p24 antigen in the blood is used as an analysis for the presence of infection with the human immunodeficiency virus. Timely diagnosis of the infectious process can prevent the spread of the virus in the population and allow you to start specific therapy as soon as possible.
What can affect the result of the test for HIV 1 and 2 antibodies and HIV 1 and 2 antigen
In rare cases, a false positive result is possible if the patient’s blood contains antibodies to the Epstein-Barr virus, rheumatoid factor, HLA major histocompatibility complex, or antibodies after the introduction of the HIV vaccine. No special preparation required. It is recommended to take blood no earlier than 4 hours after the last meal. It is advisable to conduct a test for the detection of antigen and antibodies to HIV no earlier than two weeks after a possible infection, repeating it after three and six weeks in case of a negative result.
Registration of applications for research at Invitro LLC is carried out according to a passport or a document replacing it (migration card, temporary registration at the place of residence, serviceman’s certificate, certificate from the passport office in case of loss of a passport, registration card from a hotel). The submitted document must contain information on temporary or permanent registration in the territory of the Russian Federation and a photograph. In the absence of a passport (a document replacing it), the patient has the right to make an anonymous application for the delivery of biomaterial. With an anonymous examination, the application and the biomaterial sample received from the client are assigned a number known only to the patient and the medical staff who placed the order.
Registration of applications for research by minors (under 18 years of age) is carried out exclusively in the presence of a person who has the authority to represent the interests of the minor.
The representative of a minor is obliged to present a document confirming his authority as a legal representative.
Attention! Research results performed anonymously cannot be submitted for hospitalization, occupational examinations, and are not subject to registration with the IRMS.
Indications for prescribing
In what cases is an analysis for HIV 1 and 2 antibodies and HIV 1 and 2 antigen carried out:
- swollen lymph nodes in more than two areas;
- leukopenia with lymphopenia;
- night sweats;
- sudden weight loss of unknown etiology;
- diarrhea for more than three weeks of unclear etiology;
- fever of unknown etiology;
- pregnancy planning;
- preoperative preparation, hospitalization;
- detection of the following infections or their combinations: clinically manifested toxoplasmosis, often recurrent herpesvirus infection and shingles, candidiasis of internal organs, repeated neuralgia, pneumonia caused by mycoplasmas, pneumocysts or legionella, recurrent pharyngitis and sinusitis;
- Kaposi’s sarcoma at a young age;
- unprotected sex.
Interpretation of results
Interpretation of test results contains information for the attending physician and is not a diagnosis. The information in this section should not be used for self-diagnosis or self-treatment. An accurate diagnosis is made by the doctor, using both the results of this examination and the necessary information from other sources: history, results of other examinations, etc.
Units: quality test.
Qualitative reporting format: a negative result of a screening test used by the laboratory that simultaneously detects antibodies to HIV 1 and 2 and p24 antigen results in a “negative” response. If the result of the screening combined test is positive, the serum sample is sent for further testing to the reference laboratory (see below).
Pay attention! Information on positive HIV antibody results.
Dear patients! In accordance with the regulations in force on the territory of the Russian Federation, we bring to your attention:
- In case of a positive result in a screening diagnostic test that simultaneously detects antibodies to HIV 1, 2 and p24 antigen, the analysis in the laboratory is carried out consecutively two more times (with the same serum sample and the same test system). If two positive results are obtained out of three tests, the serum is considered primary positive and is sent to the reference laboratory for further research (the laboratory of Invitro LLC Moscow is transferred to the AIDS Center, Moscow).
- The client in such situations is informed about the transfer of the sample for additional confirmatory studies to the reference laboratory and the delay in issuing the result.
- A positive or indeterminate result of confirmatory studies conducted at the AIDS Center is issued personally to the examined person or his legal representative, after the necessary explanations (post-test counseling). It is not reported by phone, e-mail, by SMS informing.
- False-positive result requiring repeat or additional testing*.
- The study is not informative in children under 18 months of age born to HIV-infected mothers (maternal antibodies may be present in the blood).
- Not infected (provided that the diagnostic timing of the analysis is observed).
- Seronegative variant of the course of infection (antibodies are produced late).
- End-stage AIDS (impaired formation of antibodies to HIV).
- The study is not informative (diagnostic terms are not met). If a negative HIV test result is obtained in individuals who have reported a high risk of HIV infection in the past three months, the HIV test should be repeated after two weeks.
- Analyzes
- Diagnosis…
- Viral infections
- Immunodeficiency virus…
- Antibodies to HIV 1 and 2 and…
- Survey program for office workers
- Household staff screening
- Cardiovascular risk assessment
- Antiphospholipid syndrome (APS) diagnosis
- COVID-19
- Liver function assessment
- Kidney and genitourinary assessment 900 06
- Diagnosis of the condition of the gastrointestinal tract
- Diagnosis of connective tissue diseases
- Diagnosis of diabetes mellitus
- Diagnosis of anemia
- Oncology
- Diagnosis and control of osteoporosis therapy
- Blood biochemistry
- Diagnosis of the state of the thyroid gland
- Hospital profiles
- Healthy, healthy country
- Gynecology, re products
- Healthy baby: for children from 0 to 14 years old
- Infections sexually transmitted diseases (STIs)
- Weight problems
- VIP examinations
- Respiratory diseases
- Allergies
- Determination of micronutrient reserves in the body
- Beauty
- Vitamins
- Diets
- Laboratory tests before dieting
- Sports profiles
- Hormonal tests for men
- De pressure
- Laboratory tests for obtaining medical certificates
- Biochemical studies
- Glucose and metabolites of carbohydrate metabolism
- Proteins and amino acids
- Bile pigments and acids
- Lipids
- Enzymes
- Markers of kidney function
- Inorganic substances/electrolytes:
- Vitamins
- Proteins involved in iron metabolism 900 06
- Cardiospecific proteins
- Markers of inflammation
- Markers of bone tissue metabolism and osteoporosis
- Determination of drugs and psychoactive substances
- Biogenic amines
- Specific proteins
- Hormonal studies
- Laboratory assessment of the pituitary-adrenal system
- Laboratory assessment of the somatotropic function of the pituitary gland
- Laboratory assessment of thyroid function
- Assessment of the function of the parathyroid glands 90 006
- Pituitary gonadotropins and prolactin
- Estrogens and progestins
- Androgenic functions
- Nonsteroidal sex gland regulatory factors
- Pregnancy monitoring, biochemical markers of fetal status
- Laboratory assessment of pancreatic endocrine function and diagnosis of diabetes
- Biogenic amines
- Laboratory assessment of the renin-angiotensin-aldosterone system
- Factors involved in the regulation of appetite and fat th exchange
- Laboratory assessment of the state of the endocrine functions of the gastrointestinal tract
- Laboratory assessment of hormonal regulation of erythropoiesis
- Laboratory evaluation of pineal gland function
- Healthy lifestyle tests
- Hematological tests
- Clinical blood test
- Immunohematological tests
- Coagulological tests (coagulus gram)
- Immunological studies
- Comprehensive immunological studies
- Lymphocytes, subpopulations
- Immunoglobulins
- Complement components
- Regulators and mediators of immunity
- Allergological studies
- IgE – allergen-specific (allergy tests), mixtures, panels, total IgE.
- IgG, allergen-specific
- ImmunoCAP technology
- AlcorBio technology
- ALEX technology
- IgE – allergen-specific (allergy tests), mixtures, panels, total IgE.
- Autoimmune disease markers
- System connective tissue diseases
- Rheumatoid arthritis, joint lesions
- Antiphospholipid syndrome
- Vasculitis and kidney lesions
- Autoimmune lesions of the gastrointestinal tract. Celiac disease
- Autoimmune liver diseases
- Neurological autoimmune diseases
- Autoimmune endocrinopathies
- Autoimmune skin diseases
- Lung and heart diseases
- Immu thrombocytopenia
- Tumor markers
- COVID-19
- Trace elements
- Aluminum
- Barium
- Beryllium
- Boron
- Vanadium
- Bismuth
- Tungsten
- Gallium
- Germanium
- Iron
- Gold
- Iodine
- Cadmium
- Potassium
- Calcium
- Cobalt
- Silicon
- Lanthanum
- Litius
- Magnesium
- Marganese
- Copper
- Molibden
- Mouse
- sodium
- Nickel
- tin
- Platinum
- Mercury
- Rubidium
- Lead
- Selenium
- Silver
- Strontium
- Antimony 9000 6
- Thallium
- Phosphorus
- Chromium
- Zinc
- Zirconium
- Study of kidney stone structure
- Research urine
- Clinical analysis of urine
- Biochemical analysis of urine
- Examination of feces
- Clinical analysis of feces
- Biochemical analysis of feces
- Sperm examination
- Light-optical examination of spermatozoa
- Antisperm antibodies
- Diagnosis of infectious diseases 900 18
- Viral infections
- Bacterial infections
- Fungal infections
- Parasitic infections
- Streptococcal infections
- Biochemical studies
- Cytological examinations
- Histological examinations
- Oncogenetic studies
- Cytogenetic studies
- Non-invasive prenatal tests
- Genetic predispositions
- Lifestyle and genetic factors
- Reproductive health
- Immunogenetics
- Rh factor
- Blood coagulation system
- Diseases of the heart and blood vessels
- Diseases gastrointestinal tract
- Diseases of the central nervous system
- Oncological diseases
- Metabolic disorders
- Description of the results of genetic studies by a geneticist
- Pharmacogenetics
- System for detoxification of xenobiotics and carcinogens
- Determining the sex of the fetus
- Rh factor of the fetus
- Hereditary diseases
- Hereditary metabolic diseases
- Hereditary metabolic diseases
- Additional tests (after screening and consultation with a specialist)
- Determination of biological relationship: paternity and motherhood
- Determination of biological relationship in the family: paternity and motherhood
- Water and soil quality study
- Water quality study
- Soil quality study
- Diagnosis of liver pathology without biopsy : FibroMax, FibroTest, SteatoScreen
- Calculated tests based on SteatoScreen results without blood sampling
- Dysbiotic conditions of the intestine and urogenital tract
- General assessment of the natural microflora of the body
- Study of the microbiocenosis of the urogenital tract
- Femoflor: profiles of studies of dysbiotic conditions of the urogenital tract in women
900 19 Specific assessment of the natural microflora of the body
- English
If two positive results are obtained out of three tests, the serum is considered primary positive and is sent to the reference laboratory for further research (the laboratory of Invitro LLC Moscow is transferred to the AIDS Center, Moscow). * The specificity of the screening test system “Antibodies to HIV 1 and 2 and antigen of HIV 1 and 2 (HIV Ag/Ab Combo, Abbott)”, according to estimates provided by the reagent manufacturer, is about 99.
6% both in the general population and in the group of patients with potential interferences (infections of HBV, HCV, Rubella, HAV, EBV, HNLV-I, HTLV-II, E. coli, Chlamydia trachomatis, etc., autoimmune pathologies ( including rheumatoid arthritis, presence of antinuclear antibodies), pregnancy, elevated levels of IgG, IgM, monoclonal gammopathy, hemodialysis, multiple blood transfusions).
Negative
Doubtful
If an indeterminate HIV test result is obtained in individuals at risk of HIV infection in the last three months, the HIV test should be repeated two weeks later.
Registration of applications for research at LLC “Invitro” is carried out according to a passport or a document replacing it (migration card, temporary registration at the place of residence, serviceman’s certificate, certificate from the passport office in case of loss of a passport, registration card from the hotel). The submitted document must contain information on temporary or permanent registration in the territory of the Russian Federation and a photograph. In the absence of a passport (a document replacing it), the patient has the right to make an anonymous application for the delivery of biomaterial.
During an anonymous examination, the application and the biomaterial sample received from the client are assigned a number known only to the patient and the medical staff who made the order.
Attention! The results of studies performed anonymously cannot be submitted for hospitalization, professional examinations, and are not subject to registration with the ORUIB.
Questions
and answers
{{{this.PREVIEW_TEXT}}}
Did the answer help you?
{{/each}}
In this section you can find out how much it costs to complete this study in your city, read the description of the test and the table for interpreting the results. When choosing where to take the analysis “Antibodies to HIV 1 and 2 and HIV 1 and 2 antigen (HIV Ag / Ab Combo)” in Moscow and other cities of Russia, do not forget that the price of the analysis, the cost of the procedure for taking biomaterial, methods and terms of research in regional medical offices may differ.
Take an HIV test, the price of an AIDS test in Yekaterinburg in Invitro
I confirm
More
org/ListItem”> INVITRO
- Blood
- Urine
- Feces
- Semen
- Gastropanel
- Endoscopy 900 06
- Functional diagnostics
- Ultrasound
- Tests we don’t do
- New tests
- Obtaining results
- Additional research orders
- Medical consultant service
- Professional position
- Venous blood for analysis
- Tumor markers. View of a practical oncologist. Laboratory justifications.
- Testosterone: diagnostic threshold, method-dependent reference values
- Laboratory assessment of lipid metabolism parameters in INVITRO
- Lipid profile: fasting or not fasting
- swollen lymph nodes in more than two areas;
- leukopenia with lymphopenia;
- night sweats;
- sudden weight loss of unknown etiology;
- diarrhea for more than three weeks of unclear etiology;
- fever of unknown etiology;
- pregnancy planning;
- preoperative preparation, hospitalization;
- detection of the following infections or their combinations: clinically manifested toxoplasmosis, often recurrent herpesvirus infection and shingles, candidiasis of internal organs, repeated neuralgia, pneumonia caused by mycoplasmas, pneumocysts or legionella, recurrent pharyngitis and sinusitis;
- Kaposi’s sarcoma at a young age;
- unprotected sex.
- In case of a positive result in a screening diagnostic test that simultaneously detects antibodies to HIV 1, 2 and p24 antigen, the analysis in the laboratory is carried out consecutively two more times (with the same serum sample and the same test system). If two positive results are obtained out of three tests, the serum is considered primary positive and is sent to the reference laboratory for further research (the laboratory of Invitro LLC Moscow is transferred to the AIDS Center, Moscow).
- The client in such situations is informed about the transfer of the sample for additional confirmatory studies to the reference laboratory and the delay in issuing the result.
- A positive or indeterminate result of confirmatory studies conducted at the AIDS Center is issued personally to the examined person or his legal representative, after the necessary explanations (post-test counseling). It is not reported by phone, e-mail, by SMS informing.
- False-positive result requiring repeat or additional testing*.
- The study is not informative in children under 18 months of age born to HIV-infected mothers (maternal antibodies may be present in the blood).
- Not infected (provided that the diagnostic timing of the analysis is observed).
- Seronegative variant of the course of infection (antibodies are produced late).
- End-stage AIDS (impaired formation of antibodies to HIV).
- The study is not informative (diagnostic terms are not met). If a negative HIV test result is obtained in individuals who have reported a high risk of HIV infection in the past three months, the HIV test should be repeated after two weeks.
View of a practical oncologist. Laboratory justifications. 9001 7
The cost of analyzes is indicated without taking biomaterial
Description
Method of determination
Chemiluminescent immunoassay, a combined test aimed at the simultaneous detection of antibodies to HIV 1, 2 and p24 antigen.
Test material
Blood serum
Attention! In case of positive and doubtful reactions, the term for issuing the result can be extended up to 10 working days.
Synonyms: Blood test for HIV1 and 2 antibodies and HIV1 and 2 antigen; HIV-1 p24; HIV-1 antigen, p24 antigen; HIV 1 and 2 antibodies and p24/25 antigen, 4th generation HIV test systems; Simultaneous qualitative determination of HIV p24 antigen and antibodies to HIV antigens types 1 and 2.
Anti-HIV, HIV antibodies, human immunodeficiency virus antibodies; HIV-1 p24, HIV-1 Ag, p24-antigen; HIV-1 and HIV-2 Antibody and Antigen Evaluation; HIV Screening Tests; AIDS Test; AIDS Screen; HIV Serology.
Test summary for Antibodies to HIV 1 and 2 and Antigen of HIV 1 and 2
Antibodies to HIV may appear as early as the second week after infection. Their content increases within 2-4 weeks and persists for many years. In 90-95% of those infected, they appear in the first three months after infection, in 5-9% – in the period from three to six months, in 0.5-1% – at a later date. After HIV infection, even before the appearance of antibodies (seroconversion), HIV antigens can be detected in serum or plasma samples. Structural nuclear protein HIV p24, which appears in the blood two weeks after infection, disappears only after two months. The test system of the 4th generation, with which this test is performed, allows, in addition to detecting antibodies to HIV 1 and 2, to detect the HIV p24 antigen.
Thus, the study can be informative even before seroconversion. This approach in the laboratory diagnosis of HIV allows for the earliest detection of infection. The special characteristics of the Invitro test used in the laboratory to detect HIV infection include the high specificity of the study: > 99.5%; 100% sensitivity of the assay to antibodies characteristic of the period of seroconversion, and the sensitivity of the test to the p24 antigen is about 18 pg/ml.
Most people with HIV antibodies may not show clinical signs of the disease (AIDS) for two to ten years or more. The procedure for conducting a laboratory examination for the presence of HIV antigens and antibodies to HIV is strictly regulated by orders of the Ministry of Health of the Russian Federation and includes the stage of a screening (screening) study by enzyme immunoassay (ELISA) methods approved for use, and the stage of a verification (confirming) study by the immunoblot method in the laboratory of the city center AIDS.
It should be noted that even the best diagnostic ELISA systems do not have 100% specificity, that is, there is some possibility of obtaining non-specific, false positive results associated with the characteristics of the patient’s blood serum. Therefore, a positive screening ELISA result may not be confirmed in a confirmatory test, after which the patient will be given a negative result. If indeterminate results are obtained in a confirmatory study, testing is repeated over time. It is recommended to re-examine after 2-3 weeks.
Laboratory diagnosis of HIV infection in children born to HIV-infected mothers has its own characteristics. In their blood up to 18 months from the moment of birth, maternal antibodies to HIV (IgG class) can circulate. The absence of antibodies to HIV in newborns does not mean that the virus has not crossed the placental barrier. Children of HIV-infected mothers are subject to laboratory diagnostic examination within 36 months after birth.
What is the purpose of testing for HIV 1 and 2 antibodies and HIV 1 and 2 antigen
The test is used to detect HIV, including at the preclinical stage of the disease.
The combined determination of specific antibodies to HIV types 1 and 2 and the HIV p24 antigen in the blood is used as an analysis for the presence of infection with the human immunodeficiency virus. Timely diagnosis of the infectious process can prevent the spread of the virus in the population and allow you to start specific therapy as soon as possible.
What can affect the result of the test for HIV 1 and 2 antibodies and HIV 1 and 2 antigen
In rare cases, a false positive result is possible if the patient’s blood contains antibodies to the Epstein-Barr virus, rheumatoid factor, HLA major histocompatibility complex, or antibodies after the introduction of the HIV vaccine. No special preparation required. It is recommended to take blood no earlier than 4 hours after the last meal. It is advisable to conduct a test for the detection of antigen and antibodies to HIV no earlier than two weeks after a possible infection, repeating it after three and six weeks in case of a negative result.
Registration of applications for research at Invitro LLC is carried out according to a passport or a document replacing it (migration card, temporary registration at the place of residence, serviceman’s certificate, certificate from the passport office in case of loss of a passport, registration card from a hotel). The submitted document must contain information on temporary or permanent registration in the territory of the Russian Federation and a photograph. In the absence of a passport (a document replacing it), the patient has the right to make an anonymous application for the delivery of biomaterial. With an anonymous examination, the application and the biomaterial sample received from the client are assigned a number known only to the patient and the medical staff who placed the order.
Registration of applications for research by minors (under 18 years of age) is carried out exclusively in the presence of a person who has the authority to represent the interests of the minor.
The representative of a minor is obliged to present a document confirming his authority as a legal representative.
Attention! Research results performed anonymously cannot be submitted for hospitalization, occupational examinations, and are not subject to registration with the IRMS.
Indications for prescribing
In what cases is an analysis for HIV 1 and 2 antibodies and HIV 1 and 2 antigen carried out:
Interpretation of results
Interpretation of test results contains information for the attending physician and is not a diagnosis. The information in this section should not be used for self-diagnosis or self-treatment. An accurate diagnosis is made by the doctor, using both the results of this examination and the necessary information from other sources: history, results of other examinations, etc.
Units: quality test.
Qualitative reporting format: a negative result of a screening test used by the laboratory that simultaneously detects antibodies to HIV 1 and 2 and p24 antigen results in a “negative” response. If the result of the screening combined test is positive, the serum sample is sent for further testing to the reference laboratory (see below).
Pay attention! Information on positive HIV antibody results.
Dear patients! In accordance with the regulations in force on the territory of the Russian Federation, we bring to your attention:
If two positive results are obtained out of three tests, the serum is considered primary positive and is sent to the reference laboratory for further research (the laboratory of Invitro LLC Moscow is transferred to the AIDS Center, Moscow). * The specificity of the screening test system “Antibodies to HIV 1 and 2 and antigen of HIV 1 and 2 (HIV Ag/Ab Combo, Abbott)”, according to estimates provided by the reagent manufacturer, is about 99.
6% both in the general population and in the group of patients with potential interferences (infections of HBV, HCV, Rubella, HAV, EBV, HNLV-I, HTLV-II, E. coli, Chlamydia trachomatis, etc., autoimmune pathologies ( including rheumatoid arthritis, presence of antinuclear antibodies), pregnancy, elevated levels of IgG, IgM, monoclonal gammopathy, hemodialysis, multiple blood transfusions).
Negative
Doubtful
If an indeterminate HIV test result is obtained in individuals at risk of HIV infection in the last three months, the HIV test should be repeated two weeks later.
Registration of applications for research at LLC “Invitro” is carried out according to a passport or a document replacing it (migration card, temporary registration at the place of residence, serviceman’s certificate, certificate from the passport office in case of loss of a passport, registration card from the hotel). The submitted document must contain information on temporary or permanent registration in the territory of the Russian Federation and a photograph. In the absence of a passport (a document replacing it), the patient has the right to make an anonymous application for the delivery of biomaterial.
During an anonymous examination, the application and the biomaterial sample received from the client are assigned a number known only to the patient and the medical staff who made the order.
Attention! The results of studies performed anonymously cannot be submitted for hospitalization, professional examinations, and are not subject to registration with the ORUIB.